Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice! Get'r done Peter!
Adding 2 milly as well! VDSC VDSC VDSC
Great volume. BHRT BHRT BHRT
What L2 service do you guys recommend to purchase? I would like to watch the bids live as well.
One would think with that news, this would be running up?
Who is selling all they hold at the opening bell? Curious?
You couldn't be more right. A world class site that finally ties all the speculation together including all the different owned ships, cruise routes, and booking dates will make this pop.
Silver will be a reality easily, if the material PR's follow the site launch over the next 30 days as stated.
VDSC VDSC VDSC
Love to see a nice gap up to sting all those weak handed sellers and shorts.
Dear Bioheart Shareholders and Friends,
As the 3rd quarter winds down, Bioheart continues to announce new strategic business efforts as well as the progression of our unique stem cell technology.
We recently announced early phase I data from the ANGEL Study being conducted in Mexico at the Hospital Angeles which has far exceeded our expectations. The strong safety profile will allow us to expand this study to additional clinical sites and enroll more patients in the US and around the world. Patients showed an average improvement in exercise capacity (or six-minute walk test) of 47 meters and 60% of the patients are walking greater than 65 meters farther at 3 months post stem cell injection. The patients are also reporting an average improvement of 13 points in their Minnesota Living with Heart Failure questionnaire. An improvement of 5 points or greater is considered “clinically meaningful” and 80% of the patients in the trial had a greater than 5 point improvement.
We are contacted often by potential investors in Asia and Latin America interested in investing in the Company. I have recently completed the prerequisite training and the vetting process is underway to take advantage of the EB5 investor visa program for immigrant investors. This visa provides a method of obtaining a green card for foreign nationals who invest money in the US. To obtain the visa, individuals must invest $1,000,000 or at least $500,000 in a “Targeted Employment Area” creating or preserving at least 10 jobs for U.S. workers excluding the investor and their immediate family. We cannot solicit investors for the program but we are certainly preparing to better answer questions and potentially take advantage of the obvious benefits for all involved. As you know, besides an advocate for regenerative medicine, I am a fervent supporter of talent development, economic development and job creation in our STEM field and our state. In that vein, I was recently appointed by Florida Governor Rick Scott to sit on the state’s board of directors of Workforce Florida, the statewide business-led workforce policy board.
We have entered into an agreement with Invitrx Therapeutics to license their adipose derived stem cell products. The team at Invitrx has been working with adipose derived stem cells for over 10 years and this experience will contribute to the development and commercialization of AdipoCell™ (Bioheart’s adipose stem cell product). We are hoping to integrate some of the techniques utilized by the team at Invitrx into our existing adipose stem cell program as we expand the ANGEL trial to additional clinical sites.
We continue to enhance our resources with the addition of two service providers — Outside Eyes and Mitrani, Rynor, Adamsky& Toland, P.A. Outside Eyes, led by Ben Porritt, is a marketing strategist who worked in the White House and has a clear understanding of both private markets and public policy. They have been engaged to support the company’s marketing plan and investor relations efforts. The marketing plan includes developing additional lines of business and revenue generators involving human and animal stem cell products. The commercial litigation law firm of Mitrani, Rynor, Adamsky & Toland, P.A. Miami and Fort Lauderdale has been hired to assist us with the protection of intellectual property rights, libel, slander and privacy protection.
I truly appreciate the ongoing flood of support of your letters and emails. I will continue to keep you posted of ongoing efforts via public filings, press releases, social media and this monthly blog. We believe that all of the above efforts will prove to be invaluable in the coming months as we prepare the market for upcoming milestones and we too realize that ongoing communication with you, our shareholders and friends of the firm, is important and key.
Thank you for your continued support and as always please reach out to me via phone or email with your comments or questions.
Warm regards,
Mike Tomas and the Bioheart Team
Glad I stacked on another 3 mil 2 days ago! GO VDSC
Bought another 2 mil. Average .0046. Now I will wait. If just one of his promises come through, this thing could fly.
Agree 100%. Awareness will create right time and place for us. Hold tight longs! BHRT
Believe me, this could put Bioheart on the radar of the big boys. Many would love to rush into this untapped market and little BHRT has a head start.
Not necessarily a bad thing, given the shear magnitude of the market share and demand. What it does do brilliantly is promote awareness and trust for the technology and therefore boosts interest and investors.
Just saw this on Fox News....Very interesting!
http://video.foxnews.com/v/2700158650001/hospital-begins-using-heart-stem-cells-in-transplant-trials/
After all the ridicule, if I were Peter, I would slam a real PR prior to market opening Monday. Gives all weekend to write it and spell check it.
VDSC VDSC VDSC
Grabbed another mil about 20 minutes ago. This think is going sideways for way to long. Seems like the bottom to me especially with this much volume. Normal trading on this with no news and this volume would have been all down hill.
GO VDSC
Got another mil @ .001. Good stuff!
VDSC VDSC VDSC
Run Forest Run!
SUNRISE, FL, Sep 26, 2013 (Marketwired via COMTEX) -- Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage, announced today preliminary data from its phase I ANGEL Trial. Fully funded by Bioheart, the trial is being conducted in Mexico at the Hospital Angeles in conjunction with the Regenerative Medicine Institute (RMI).
"The preliminary Phase I data has far exceeded our expectations. In addition, the strong safety profile demonstrated will allow us to expand this study to additional clinical sites and enroll more patients," said Kristin Comella, Bioheart's Chief Science Officer. This phase I study will provide necessary safety and preliminary efficacy of adipose derived stem cells (AdipoCell(TM)) in patients with congestive heart failure. Endpoints include safety, exercise capacity, quality of life, and ejection fraction at 3 months, 6 months and 12 months.
At the 3 month time point, patients are demonstrating an average improvement in exercise capacity or a six minute walk test of 47 meters. In addition, 60% percent or a majority of the patients are walking greater than 65 meters further at 3 months post stem cell injection.
The patients are also reporting an average improvement of 13 points in their Minnesota Living with Heart Failure questionnaire. An improvement of 5 points or greater is considered "clinically meaningful" and 80% of the patients in the trial had a greater than 5 point improvement.
About Bioheart, Inc.
News out! Trials Positive
Have a 1 mil order in now! .001.
Hi Pam,
I own 700k shares all bought at a higher PPS. I am thinking of going another 100k. It seems to me that first trial results are close and new blog is due both of which will push this higher. IMO a good time to buy.
Could of been way worse based on the paranoia generated over the new shares yesterday. If even half of what Peter promised happens, this all will be a nonissue and an unapologetic rocket to silver. Strong handed longs, stayed strong and look at today's results. VDSC VDSC VDSC!
From your earlier posts of frustration to utter excitement, I have no doubt that you are being genuine. On that note, I am thinking of adding another mil to my 6. In that Peter expressed a need for patients, I may wait to see just how far MM's will drive it down before pulling the trigger. Thx for the update!
VDSC VDSC VDSC
Me like-a the hunch! Go VDSC
Curious....What makes think PR today?
Sweet pic
Think it will see copper again?
For stock that was suppose to crash immediately.....It sure looks like it has footing. VDSC
VDSC about to EXPLODE!!!!!!!
Buying another 100k at these low levels...
Really feels like we are sitting on a Time Bomb! VDSC ready to explode!
Grabbed 450k more at .0050. Holding 6 mil. Let's roll VDSC
Great post! Thx!
How old are you? Your writing is in the range of an eight year old. Does your Mommy know you are playing on the computer?
Good point, the stock has held it's own without any news. I am impressed as well. Watch out, it now has legs. You better cover while you can and go long.
Run Forest Run! jenny, "I know what love is".